Intensity of statin therapy in primary and secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
m (Bot: Adding CME Category::Cardiology) |
||
| Line 19: | Line 19: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 24: | Line 28: | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
Revision as of 18:58, 14 March 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The intensity of statin therapy is defined on the basis of the average expected LDL response to a specific statin and dose. High-intensity statin daily therapy lowers LDL by approximately ≥50%, moderate-intensity statin lowers LDL by approximately 30% to <50%, and lower-intensity statin lowers LDL by <30%.[1]
High-, Moderate-, and Low-Intensity Statin Therapy
| High-Intensity Statin Therapy | Moderate-Intensity Statin Therapy | Low-Intensity Statin Therapy |
| Atorvastatin (40†)–80 mg Rosuvastatin 20 (40) mg |
Atorvastatin 10 (20) mg Rosuvastatin (5) 10 mg Simvastatin 20–40 mg‡ Pravastatin 40 (80) mg Lovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2–4 mg |
Simvastatin 10 mg Pravastatin 10–20 mg Lovastatin 20 mg Fluvastatin 20–40 mg Pitavastatin 1 mg |
References
- ↑ "2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults". Retrieved 13 November 2013.